Spotlight Session | Live Case &
Late-Breaking Trials from TCT
November 9, 2024
9:00 AM ET
Welcome and Introduction
Ron Waksman, MD
LIVE CASE | MEDSTAR WASHINGTON HOSPITAL CENTER
9:05 AM ET
Live Case | Broadcasting From MedStar Washington Hospital Center | Washington, DC
Live Case Operators: Itsik Ben-Dor, MD | Lowell Satler, MD
Live Case Moderator(s): Maurice Buchbinder, MD | Ron Waksman, MD
Live Case Discussant(s): George Dangas, MD | Annapoorna Kini, MD | Giorgio Medranda, MD
LATE-BREAKING TRIALS | TCT
Moderator(s): David Cohen, MD | Ron Waksman, MD
Panel Discussant(s): Samir Kapadia, MD | Azeem Latib, MD | Bernard Prendergast, MD
10:00 AM ET
Early TAVR: Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial
Speaker: Philippe Genereux, MD
10:15 AM ET
Panel Discussion
Moderator(s): David Cohen, MD | Ron Waksman, MD
Panel Discussant(s): Samir Kapadia, MD | Azeem Latib, MD | Bernard Prendergast, MD
10:25 AM ET
TAVR UNLOAD: Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis
Speaker: Nicholas M. Van Mieghem
10:40 AM ET
Panel Discussion
Moderator(s): David Cohen, MD | Ron Waksman, MD
Panel Discussant(s): Samir Kapadia, MD | Azeem Latib, MD | Bernard Prendergast, MD
10:50 AM ET
ECLIPSE: A Large-Scale, Randomized Trial of Orbital Atherectomy vs. Conventional Balloon Angioplasty in Severely Calcified Coronary Arteries Prior to DES Implantation
Speaker: Ajay J. Kirtane, MD
11:05 AM ET
Panel Discussion
Moderator(s): David Cohen, MD | Ron Waksman, MD
Panel Discussant(s): Samir Kapadia, MD | Azeem Latib, MD | Bernard Prendergast, MD
11:15 AM ET
TRISCEND II: Randomized Comparison of Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation
Suzanne V. Arnold, MD
11:30 AM ET
Panel Discussion
Moderator(s): David Cohen, MD | Ron Waksman, MD
Panel Discussant(s): Samir Kapadia, MD | Azeem Latib, MD | Bernard Prendergast, MD
11:40 AM ET
The ACURATE IDE Trial | Evaluating Safety and Effectiveness of the Tranfemoral ACURATE™ Aortic Valve Platform for Transcatheter Aortic Valve Replacement (TAVR) in Subjects with Severe Native Aortic Stenosis who are Indicated for TAVR
Speaker: Michael Reardon, MD
11:55 AM ET
Panel Discussion
Moderator(s): David Cohen, MD | Ron Waksman, MD
Panel Discussant(s): Samir Kapadia, MD | Azeem Latib, MD | Bernard Prendergast, MD
